UCreate3 acceleration program from the UNIL’s Entrepreneurial and Innovation HUB is designed for all members of the UNIL community : students, researchers, professors, employees and alumni. This interdisciplinary program is open to the 7 faculties of UNIL and supports all types of projects. Projects with a social and/or environmental impact are specifically encouraged.

Do you have a project that you want to launch? Embark on the entrepreneurial adventure in 2021! The main objective of the UCreate3 program is to encourage, facilitate and accelerate the creation and development of innovative projects. The program is supervised by experts, coaches and trainers who will accompany the participants during 16 weeks.
A co-working space is available at the UNIL Accelerator. All training sessions of the program are held at the Accelerator (if the sanitary situation permits, otherwise they will be held online).

The main goals of UCreate3 :
• Encourage all types of innovative projects, whether they are technological or not
• Accompany and support the selected projects throughout the acceleration process with several training sessions and expert coaching
• Follow up on projects and candidates to increase the potential of success
• Facilitate collaboration within the 7 faculties

The advantages of UCreate3 :
• Take part in training sessions
• Benefit from the support of a dedicated coach
• Improve your skills with experienced entrepreneurs
• Benefit from a network of entrepreneurs
• Receive financial support up to CHF 10,000.- per project
• Access to an office in our co-working space at the UNIL Accelerator (250 m2)

For more information about UCreate3 acceleration program and the next deadline for the call of project please visit https://ucreate.ch/en/ucreate3-en/

PACTT is pleased to announce that Dr. Josefine Trawal was awarded the InnoTREK/FIT grant for the project miniMarrow as part of the Spring 2021 FIT’s call of projects candidacy.

Stemming from a technology developed at CHUV, EPFL and UNIGE and applied to a cell therapy, miniMarrow allows the subcutaneous injection of a bio-material cultured with bone marrow cells, enabling the patient himself to produce in-vivo blood platelet. Such type of treatment aims at patient suffering from haematological malignancies such as blood cancers, leukaemias and lymphomas. Such pathologies requires currently 4 to 8 monthly platelet transfusions to the patient. miniMarrow contemplates to achieve the same therapeutic effect with only one monthly injection.

Before participating to the InnoTREK/FIT selection process, the miniMarow team was supported by the Ucreate3 program form the UNIL’s Entrepreneurial and Innovation HUB. Josefine and her team were coached by experts so as to develop entrepreneur’s skills, clarify market needs and setup initial approaches for their business model.

This CHF 100’000 grant will allow Dr Josefine Tratwal to develop further her project and to create a start-up. During this yearly grant, Josefine will be hosted in Professor Olaia Naveiras’ regenerative haematopoiesis research laboratory.

PACTT’s team is proud to support this ambitious project, precursor of a new therapeutic approach with multiple social benefits.

Venture Leaders Technology brings 10 innovative Swiss startups to the Silicon Valley from November 1st to November 6th, 2021 for a week of intensive networking, business development and investor pitching. This will be an exclusive opportunity to get to know investors and international industry experts as a member of the “Swiss National Startup team”.

Until July 18th, 2021 startups will be able to apply for one of the 10 highly coveted slots. The program (worth about 10.000CHF) is organized by Venturelab and supported by EPFL, ETH, DPD, Intel, Kellerhals Carrard, Rothschild & Co and Canton Vaud, facilitating the participation free of charge for the startups.

Information & registration

Flyer

Swiss precision medicine biotech Haya Therapeutics is coming out of stealth mode with CHF 18 million in seed funding to boost its anti-fibrotic therapies.

The underlying science was initially conducted by Dr. Samir Ounzain and Professor Thierry Pedrazzini of Experimental Cardiology Unit at CHUV and published in top scientific journals.

The project won support by an InnoTREK grant from the PACTT who protected the lead target sequence WISPER and several additional long non-coding RNAs that were licensed to Haya Therapeutics.
We are thrilled the team is now set to develop the technology to provide promising novel treatment options for patients.

Well done to all the team!

Venture Leaders Biotech brings 10 innovative Swiss startups to China from September 6th to 10th, 2021 for a week of intensive networking, business development and investor pitching. This will be an exclusive opportunity to get to know investors and international industry experts as a member of the “Swiss National Startup Team”.

Until April 25th, 2021 startups will be able to apply for one of the 10 highly coveted slots. The program (worth about 10.000CHF) is co-organized by Venturelab and swissnex China supported by EPFL, ETH, Vischer and Canton Zürich, facilitating the participation free of charge for the startups.

Program and Registration

Flyer

Spring CALL 2021

You are a UNIL-CHUV researcher who would like to create a start-up and need a financial support to start?

Apply for a one-year InnoTREK grant of CHF 100’000.- to launch your project!

PACTT, the Technology Transfer Office of UNIL-CHUV, is calling for start-up projects in order to award the InnoTREK grant. As part of the InnoPACTT financial support, the InnoTREK grant is designed to accelerate innovation and UNIL-CHUV spin-off creation, and to encourage researchers with innovative ideas to jump into the entrepreneurship adventure.

Deadline for submission: April 5, 2021

For conditions, registration form and information: www.pactt.ch/innotrek/

Contact: innopactt.info@chuv.ch

021 314 39 84 / 021 314 49 58 / 021 314 82 19

Superlab Suisse AG, a Zurich-based private company offering the concept – unique in Switzerland – of the Lab as a Service to life sciences companies, is launching its first branch at Biopôle, Lausanne. The centre will open by the end of the second quarter of 2021 and will host up to 15 companies and projects. Through this partnership, Biopôle SA continues its unwavering support for the local innovation ecosystem and the creation and development of young start-ups in the canton of Vaud.

Read more

La Fondation Asile des aveugles lance un Prix de l’innovation récompensant et encourageant tous les dispositifs favorisant l’insertion professionnelle des personnes atteintes dans leur santé visuelle. Grâce au soutien du Fonds Ingvar Kamprad, trois projets recevront un prix pour un montant total de CHF 60’000. La remise du prix aura lieu le 9 septembre 2021 à Lausanne, lors du Symposium Insertion professionnelle pour personnes en situation de handicap visuel.

Informations pratiques et participation:
Les projets doivent être soumis d’ici au 31 mai 2021 à l’adresse portails@fa2.ch. Le règlement complet du Prix de l’innovation ainsi que les informations relatives au Symposium peuvent être consultés sur : https://events.ophtalmique.ch. Tous les projets qui présentent un apport pour les personnes concernées pourront faire l’objet d’un partenariat avec la Fondation Asile des aveugles.
Durant l’été 2021, les projets soumis et les résultats des projets de recherche appliquée seront diffusés auprès des acteurs et actrices du terrain (personnes en situation de handicap, leurs familles, les accompagnant-e-s et les professionnel-le-s) ainsi qu’auprès du grand public.

Communiqué de presse

The direction of the University of Lausanne supports the development of entrepreneurial ideas and projects from all 7 faculties. Hence, the University offers you the opportunity to take part in the UCreate3 acceleration program powered by the HUB Entrepreneurship and Innovation of UNIL.

Do you have a project that you want to launch? Embark on the entrepreneurial adventure! The main objective of the UCreate3 program is to encourage, facilitate and accelerate the creation and development of 8 innovative projects per semester. The program is supervised by experts, coaches and trainers who will accompany the participants during 16 weeks.

A co-working space is available at the UNIL Accelerator. All training sessions of the program are held at the Accelerator (if the sanitary situation permits, otherwise they will be held online).

The main goals of UCreate3 :
• Encourage all types of innovative projects, whether they are technological or not
• Accompany and support the selected projects throughout the acceleration process with several training sessions and expert coaching
• Follow up on projects and candidates to increase the potential of success
• Facilitate collaboration within the 7 faculties

The advantages of UCreate3 :
• Take part in training sessions (+20 hours)
• Benefit from the support of a dedicated coach
• Improve your skills with experienced entrepreneurs
• Benefit from a network of entrepreneurs
• Receive financial support up to CHF 10,000.- per project
• Access to an office in our co-working space at the UNIL Accelerator (250 m2)

For more information about UCreate3 acceleration program and the next deadline for the call of project please visit : https://ucreate.ch/en/ucreate3-en/

PACTT is proud to announce that Artemis, a project led by Laurent Vinet, is the winner of the Best Life Sciences Project Innosuisse.

Laurent was awarded with an InnoTREK/FIT grant in spring 2020 for Artemis, a project born from close collaboration between CHUV and UNIGE. Artemis develops a biodegradable local drug delivery system to prevent vein stenosis. Laurent has started 6 months of coaching by Geneus (www.geneus.ch) with Nandkishor Mule and Si Gou, his project partners in the Innosuisse Business Concept training.

Join PACTT in congratulating Laurent Vinet and the Artemis team, and wishing them great success as their project develops!